These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M. J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590 [Abstract] [Full Text] [Related]
3. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. Lowe J, Brown B, Hardie D, Richardson P, Ling N. Immunol Lett; 1989 Jan 31; 20(2):103-9. PubMed ID: 2523865 [Abstract] [Full Text] [Related]
4. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells. Almerigogna F, Biagiotti R, Giudizi MG, Alessi A, Ricci M, Bosi A, Romagnani S. Ric Clin Lab; 1989 Jan 31; 19(2):129-38. PubMed ID: 2528201 [Abstract] [Full Text] [Related]
5. Soluble CD23 in the serum of children with ascariasis. Hamada A, Watanabe N, Yanagihara Y, Barbosa I, Tateno S, Kobayashi A. Trans R Soc Trop Med Hyg; 1991 Jan 31; 85(4):529-30. PubMed ID: 1836688 [No Abstract] [Full Text] [Related]
6. CD23: a multi-functional receptor/lymphokine? Gordon J, Flores-Romo L, Cairns JA, Millsum MJ, Lane PJ, Johnson GD, MacLennan IC. Immunol Today; 1989 May 31; 10(5):153-7. PubMed ID: 2525911 [Abstract] [Full Text] [Related]
7. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E. Blood; 1991 Oct 01; 78(7):1795-802. PubMed ID: 1717071 [Abstract] [Full Text] [Related]
8. CD23: novel disease marker with a split personality. Gordon J. Clin Exp Immunol; 1991 Dec 01; 86(3):356-9. PubMed ID: 1836159 [No Abstract] [Full Text] [Related]
9. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Bujanowski-Weber J, Brings B, Knöller I, Pfeil T, König W. Immunology; 1989 Apr 01; 66(4):505-11. PubMed ID: 2523859 [Abstract] [Full Text] [Related]
10. Heterogeneity of CLL: high CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation. Dadmarz R, Cawley JC. Br J Haematol; 1988 Mar 01; 68(3):279-82. PubMed ID: 2965599 [Abstract] [Full Text] [Related]
11. Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, Yabuta K. Clin Immunol Immunopathol; 1990 Aug 01; 56(2):280-6. PubMed ID: 1696189 [Abstract] [Full Text] [Related]
12. Immunoelectron microscopic characterization of a subpopulation of freshly isolated epidermal Langerhans cells that reacts with anti-CD23 monoclonal antibody. Torresani C, Manara GC, Ferrari C, De Panfilis G. Br J Dermatol; 1991 Jun 01; 124(6):533-7. PubMed ID: 1829625 [Abstract] [Full Text] [Related]